Illumina, Inc. (NASDAQ:ILMN ) Q3 2022 Earnings Conference Call November 3, 2022 5:00 PM ET Company Participants Salli Schwartz - Vice President of Investor Relations Francis deSouza - President & Chie
Illumina (ILMN) delivered earnings and revenue surprises of 17.24% and 1.33%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
It's true that the troika of Microsoft (NASDAQ: MSFT ), Alphabet (NASDAQ: GOOG , NASDAQ: GOOGL ), and Meta (NASDAQ: META ), much loved by the Street for the decade that ended in mid-2021, reported dis
Bionano's stock price movements have little to do with its successes.
The extended lockdown issues in limited geographies, including Greater China, where Illumina (ILMN) has extensive business, are expected to have adversely impacted its top line during the third quarte

Illumina Is Critically Undervalued

06:24pm, Friday, 21'st Oct 2022
A few months ago, gene sequencing juggernaut Illumina Inc. ( ILMN , Financial) seemed like it was well on its way to becoming a fallen giant. Amid flagging growth, the company had jumped the gun by re
Illumina is the dominant player in gene sequencing.
There is more to the comparison, and in the sections below, we discuss why we believe ILMN stock will offer better returns than TMO stock in the next three years.
SAN DIEGO , Oct. 6, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the third quarter 2022 following the close of market on Thursday, November 3, 2022

Technical Trouble Haunts This Medtech Name

12:20pm, Thursday, 06'th Oct 2022
The shares of Illumina, Inc. (NASDAQ:ILMN) got a kick from this week's broad-market rally, surging 9.5% on Tuesday to mark its biggest one-day jump since January.
Genome sequencing solutions company Illumina (NASDAQ: ILMN) stock has fallen under its pandemic lows. A surprise earnings miss, and lowered guidance has caused

Illumina Debuts Faster Genomics Sequencer

07:38pm, Thursday, 29'th Sep 2022
Illumina CEO Francis deSouza speaks with Ed Ludlow about the debut of a new DNA sequencer and the latest advances in genomic/molecular testing. -------- Like this video?

3 Biotech Stocks to Sell in October

03:59pm, Thursday, 29'th Sep 2022
This year will probably go down as the roughest year for investors since the financial recession in 2008. The S&P 500 has shed more than 20% of its value year-to-date as inflation and interest rates w
The "Halftime Report" traders give their top picks to watch for the second half.

The 3 Best Healthcare Stocks to Buy Now

06:00pm, Friday, 09'th Sep 2022
With the exception of energy and utilities, all sectors of the S&P 500 are in the red for the year. Of the losing sectors, healthcare stocks have held up relatively well, outperformed only by consumer
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE